Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy

Published:2016-12-14 Issue:1 Volume:28 Page:103-108
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:J Cardiovasc Electrophysiol

Author:

FRANCIA PIETRO¹,ADDUCI CARMEN¹,SEMPRINI LORENZO¹,PALANO FRANCESCA¹,SANTINI DARIA¹,MUSUMECI BEATRICE¹,SANTOLAMAZZA CATERINA¹,VOLPE MASSIMO¹²,AUTORE CAMILLO¹

Affiliation:

1. Cardiology, Department of Clinical and Molecular Medicine, St. Andrea Hospital; Sapienza University; Rome Italy

2. IRCCS Neuromed; Pozzilli (IS); Italy

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jce.13121/fullpdf

Reference34 articles.

1. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy;Maron;N Engl J Med,2000

2. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy;Maron;JAMA,2007

3. Measurement of cardioversion/defibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration;Winkle;Circulation,1984

4. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: The NORDIC ICD randomized clinical trial;Bänsch;Eur Heart J,2015

5. Cardioverter defibrillator implantation without induction of ventricular fibrillation: A single-blind, non-inferiority, randomised controlled trial (SIMPLE);Healey;Lancet,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-04

2. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy;Journal of the American College of Cardiology;2024-06

3. Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator;Europace;2023-08-02

4. Implantable cardioverter-defibrillators for hypertrophic cardiomyopathy: The Times They Are a-Changin’;EP Europace;2021-12-30

5. The Role of Subcutaneous ICDs in the Prevention of Sudden Cardiac Death;US Cardiology Review;2021-10-21